Success Stories: Reinforcing U.S. Leadership in AI-Driven Healthcare: NIW Granted

Client’s Testimonial:

“I have an approved NIW application thanks to you all.”

On January 29^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical R&D Analytics Manager in the Field of Clinical Data Analytics (Approval Notice).

General Field: Clinical Data Analytics

Position at the Time of Case Filing: Clinical R&D Analytics Manager

Country of Origin: Iran

State of Residence at the Time of Filing: South Carolina

Approval Notice Date: January 29^th, 2025

Processing Time: 2 months (Premium Processing Requested)

Case Summary:

With healthcare systems under increasing pressure to deliver faster, safer, and more effective treatments, the integration of artificial intelligence (AI) into clinical research has become a national priority. Our client, an accomplished expert in clinical data analytics, is at the forefront of this transformation. By combining advanced data science methodologies with real-world healthcare challenges, his work is reshaping drug development, clinical trial design, and public health strategies.

Why His Work Matters
Drug development is one of the most resource-intensive aspects of healthcare, with costs reaching up to $2 billion per approved therapy and only a fraction of trials resulting in successful outcomes. Our client’s research directly addresses these challenges by:

Using AI models to streamline and automate clinical trial protocols.
Leveraging data science to uncover disparities in vaccine hesitancy and healthcare access.
Developing predictive tools for more accurate diagnostics and improved patient outcomes.

This blend of innovation and practical application ensures that his research delivers not only academic contributions but also tangible improvements in public health and cost efficiency.

Evidence of Excellence
The client’s expertise is demonstrated through a strong record of publications and peer recognition. He has authored 2 peer-reviewed journal articles, 4 abstracts, and 5 preprints, with two of his works ranking among the most highly cited in Social Sciences, General for their publication years. His research has already been cited 43 times by independent scholars across the globe, showing broad reliance on his findings. Beyond authorship, he has strengthened the scientific community by conducting at least 26 peer reviews for respected journals.

Endorsement from Experts
Leaders in the field have strongly affirmed the importance of his contributions. One expert summarized his impact by stating:

“His insights therefore optimized clinical trials, enhanced diagnostic accuracy, and advanced patient care, reinforcing the integration of artificial intelligence into clinical research and healthcare to achieve more efficient, precise, and effective outcomes.”

The Path Forward with NIW Approval
With USCIS granting his NIW petition, successfully prepared and filed by North America Immigration Law Group (NAILG), our client is well-positioned to continue advancing AI-driven solutions for healthcare. His ongoing research will support U.S. efforts to reduce drug development costs, improve patient care, and maintain global leadership in the application of artificial intelligence to medicine.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.